I Mab Valuation
| IMABDelisted Stock | USD 4.64 0.06 1.28% |
At this time, the entity appears to be overvalued. I Mab retains a regular Real Value of $4.09 per share. The prevalent price of the entity is $4.64. Our model calculates the value of I Mab from analyzing the entity fundamentals such as return on asset of -0.1, and Shares Outstanding of 115.27 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that I Mab's price fluctuation is very risky at this time. Calculation of the real value of I Mab is based on 3 months time horizon. Increasing I Mab's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since I Mab is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IMAB Stock. However, I Mab's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.64 | Real 4.09 | Hype 4.64 | Naive 3.33 |
The real value of IMAB Stock, also known as its intrinsic value, is the underlying worth of I Mab Company, which is reflected in its stock price. It is based on I Mab's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of I Mab's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of I Mab helps investors to forecast how IMAB stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of I Mab more accurately as focusing exclusively on I Mab's fundamentals will not take into account other important factors: I Mab Total Value Analysis
I Mab is currently forecasted to have valuation of 313.92 M with market capitalization of 533.68 M, debt of 3.88 M, and cash on hands of 3.92 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the I Mab fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
313.92 M | 533.68 M | 3.88 M | 3.92 B |
I Mab Asset Utilization
One of the ways to look at asset utilization of IMAB is to check how much profit was generated for every dollar of assets it reports. I Mab retains a negative application of resources of -0.1 (percent), losing $0.001036 for each dollar of resources held by the entity. Ineffective asset utilization attests that the company is being less competent with each dollar of resources it retains. Simply put, asset utilization of I Mab shows how unsuccessful it operates for each dollar spent on its resources.I Mab Ownership Allocation
I Mab has a total of 115.27 Million outstanding shares. I Mab secures tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the entity is less than the current market value, you may not be able to make money on it.I Mab Profitability Analysis
Net Loss for the year was (49.7 M) with profit before overhead, payroll, taxes, and interest of 41.59 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates I Mab's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in I Mab and how it compares across the competition.
About I Mab Valuation
The delisted stock valuation mechanism determines I Mab's current worth on a weekly basis. Our valuation model uses a comparative analysis of I Mab. We calculate exposure to I Mab's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of I Mab's related companies.I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. The company was founded in 2014 and is headquartered in Shanghai, the Peoples Republic of China. I-Mab ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 378 people.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in IMAB Stock
If you are still planning to invest in I Mab check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the I Mab's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |